1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,400 | 2,440 | 18:59 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.05. | Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors | 321 | PR Newswire | TAMPERE, Finland, May 26, 2023 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland.
The Annual General Meeting approved the financial... ► Artikel lesen | |
| 16.05. | Former U.S. White House Surgeon and FDA Medical Officer joins Bioretec team | 242 | PR Newswire | Bioretec Ltd Press release 16 May 2023 at 10:00 a.m. EEST
TAMPERE, Finland, May 16, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, announces... ► Artikel lesen | |
| 05.05. | Notice to the Annual General Meeting of Bioretec Ltd | 1 | Cision News | ||
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 28.04. | Bioretec Ltd: 5 000 000 new shares registered with the trade register | - | Cision News | ||
| 28.04. | INSIDE INFORMATION: Bioretec Ltd successfully completes private placement raising EUR 10 million | 362 | PR Newswire | THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED... ► Artikel lesen | |
| 27.04. | INSIDE INFORMATION: Bioretec Ltd launches an accelerated book-building process to raise approximately EUR 10 million through a private placement of new shares | 279 | PR Newswire | Bioretec Ltd Inside information 27 April 2023 at 6:31 p.m. EEST
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA... ► Artikel lesen | |
| 26.04. | New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register | 1 | Cision News | ||
| 24.04. | INSIDE INFORMATION: Bioretec updates its product pipeline to accelerate commercialization strategy following the first RemeOs FDA market authorization, and consequently updates financial targets | 212 | PR Newswire | Bioretec Ltd Inside information 24 April 2023 at 1.15 p.m. EEST
TAMPERE, Finland, April 24, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioabsorbable orthopedic implants, announced... ► Artikel lesen | |
| 30.03. | FDA approves bioresorbable metal implant from Bioretec | 4 | MassDevice | ||
| 30.03. | Bioretec is the first in the world to receive FDA approval for a bioresorbable metal product | 309 | PR Newswire | TAMPERE, Finland, March 30, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable[1] orthopedic implants, has today announced receiving the market authorization of the U.S. Food and... ► Artikel lesen | |
| 30.03. | FDA approves Bioretec's RemeOs trauma screw as the first bioresorbable metal implant in the U.S. market | 361 | PR Newswire | TAMPERE, Finland, March 30, 2023 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable[1] orthopedic implants, has today received market authorization for its RemeOs trauma screw in the... ► Artikel lesen | |
| 17.03. | Bioretec postpones Annual General Meeting to a later date | 342 | PR Newswire | Bioretec Ltd Company announcement 17 March 2023 at 4.45 EET
TAMPERE, Finland, March 17, 2023 /PRNewswire/ -- Bioretec Ltd's Board of Directors has today decided to reschedule the date... ► Artikel lesen | |
| 17.03. | Bioretec Ltd's Annual Report and Financial Statements 2022 are published | 349 | PR Newswire | TAMPERE, Finland, March 17, 2023 /PRNewswire/ -- Bioretec Ltd has today published its 2022 Annual Report, Report by the Board of Directors, and Financial Statements. The publications are... ► Artikel lesen | |
| 17.02. | Bioretec Ltd's financial statements bulletin 2022: We are delighted about the sales growth and look forward to future approvals | 301 | PR Newswire | TAMPERE, Finland, Feb. 17, 2023 /PRNewswire/ -- This is a summary of Bioretec Ltd's financial statements bulletin for January-December 2022. The complete financial statements bulletin with... ► Artikel lesen | |
| 10.01. | Bioretec Ltd - Managers' transactions | 4 | Cision News | ||
| 04.01. | Bioretec has submitted additional information requested by the FDA for US registration of RemeOs Trauma Screws, and the estimated approval timeline of April 2023 remains unchanged | 461 | PR Newswire | TAMPERE, Finland, Jan. 4, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has finalized the supplement for market authorization request in accordance with... ► Artikel lesen | |
| 20.12.22 | Bioretec's financial information and Annual General Meeting in 2023 | 302 | PR Newswire | TAMPERE, Finland, Dec. 20, 2022 /PRNewswire/ --
Bioretec will publish the following financial information in 2023:
Financial Statements Bulletin January-December 2022 on Friday... ► Artikel lesen | |
| 15.12.22 | Bioretec participated in Inderes Life Science Evening | - | Cision News | ||
| 08.12.22 | Bioretec to participate in Inderes Life Science Evening | 2 | Cision News | ||
| 04.11.22 | Bioretec updates its estimate of the timing for approval of the CE mark for the RemeOs trauma screw | 386 | PR Newswire | Bioretec Ltd Inside information 4 November 2022 at 6:15 p.m. EET
TAMPERE, Finland, Nov. 4, 2022 /PRNewswire/ -- Bioretec Ltd, a pioneer in biodegradable orthopedic implants, expects... ► Artikel lesen |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 26,230 | +1,86 % | Cordoba 78 Cup by BSN, stock3 & Captrace: Polytec, Fresenius ... | Der Cordoba 78 Cup von BSN, stock3 und Captrace ist ein Ausscheidungsrennen aus 39 Aktien aus dem DAX40 und 39 Aktien aus dem ATXPrime41. Vor Start wurde aus dem DAX Covestro, der Titel mit der schwächsten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 53,80 | +0,86 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014 (MAR) i.V.m. Art. 2 Abs. 2, Abs. 3 der Delegierten... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 111,60 | +2,39 % | Carl Zeiss Meditec-Aktie mit leichten Kursgewinnen (107,80 €) | Im Plus liegt derzeit die Aktie von Carl Zeiss Meditec . Der jüngste Kurs betrug 107,80 Euro. Ein Preisanstieg von 2,81 Prozent steht gegenwärtig für die Carl Zeiss Meditec-Aktie zu Buche. Das Wertpapier... ► Artikel lesen | |
| INARI MEDICAL | 62,23 | -0,14 % | Inari Medical, Inc.: Inari Medical Reports First Quarter 2023 Financial Results | IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous... ► Artikel lesen | |
| NANO-X IMAGING | 21,270 | +17,45 % | 2 Medical Imaging Stocks That Are Better Buys Than Nano-X | ||
| PROGYNY | 39,020 | +3,06 % | Progyny, Inc. Announces First Quarter 2023 Results | Reports Record Quarterly Revenue of $258.4 Million, Reflecting 50% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Demand Continues for Family Building Solutions... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,580 | +0,92 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat FMC nach Quartalszahlen und einem Kapitalmarkttag auf "Underperform" mit einem Kursziel von 21 Euro belassen. Angesichts anhaltender fundamentaler... ► Artikel lesen | |
| GERRESHEIMER | 106,80 | +2,40 % | PRESSESPIEGEL/Unternehmen: GERRESHEIMER, ENBW, TESLA, THALES, PROXIMA FUSION, VINFAST | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
GERRESHEIMER - Gerresheimer-Chef Dietmar Siemssen hat starke Jahre in... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,840 | +1,93 % | Privia Health Group, Inc.: Privia Health to Participate in Upcoming Investor Conferences | ||
| ADAPTHEALTH | 10,500 | -0,57 % | AdaptHealth Corp. Announces First Quarter 2023 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| ATRICURE | 46,930 | +2,51 % | AtriCure Reports First Quarter 2023 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| AGILON HEALTH | 20,220 | +4,90 % | What 6 Analyst Ratings Have To Say About Agilon Health | ||
| PROCEPT BIOROBOTICS | 32,500 | +0,03 % | PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance | REDWOOD CITY, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing... ► Artikel lesen | |
| TREACE MEDICAL CONCEPTS | 26,780 | +1,02 % | What 5 Analyst Ratings Have To Say About Treace Medical Concepts | ||
| OUTSET MEDICAL | 22,320 | +2,24 % | Outset Medical, Inc. - 8-K, Current Report |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
